x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:25:11

Prime Medicine's new CEO Allan Reine walks us through...

BiotechTV - News ·

2025/07/17

He describes the benefits of prime editing, walks us through human proof-of-concept data that was announced in a patient with Chronic Granulomatous Disease, and explains the rationale to focus on Wilson's Disease, Alpha-1 Antitrypsin Deficiency, Cystic Fibrosis, and the company's CAR-T partnership with Bristol Myers Squibb.

en-us

00:30:39

Kailera Therapeutics' partner Hengrui announced...

BiotechTV - News ·

2025/07/16

He describes why Kailera chose to in-license a GLP1/GIP specifically, and describes where he sees this asset placing in the competitive landscape based on this data. Plus, commentary on CMC, business development, oral therapies, and more.

en-us

00:11:59

Southampton professor, and Curve Therapeutics' CSO,...

BiotechTV - News ·

2025/07/16

He describes the properties that make cyclic peptides unique compared to small molecules and antibodies, and how Curve's approach is different than others in the field. Plus, the work his team is doing on cyclic peptides in their lab at University of Southampton.

en-us

00:15:28

Southampton, UK based Curve Therapeutics believes its...

BiotechTV - News ·

2025/07/15

Co-Founder and CEO Simon Kerry discusses being in Southampton, and why he belives the 'Microcycle' platform beats screening in traditional well plates for discovery work. Curve currently has cash on hand to take at least one program into the clinic.

en-us

00:31:38

Checking in with MoonLake's CEO ahead of one of...

BiotechTV - News ·

2025/07/11

Jorge Santos da Silva walks us through the scientific design of the molecule, which is a nanobody that binds to IL-17A, IL-17F, and albumin. He compares and contrasts it to key competitor BIMZELX and describes what the company is hoping to see in the trial readout. Plus, commercial plans, pipeline, and more.

en-us

00:21:58

KalVista's CEO discusses today's FDA approval and...

BiotechTV - News ·

2025/07/07

Ben Palleiko is asked about the company's take on headlines that were in the news during the FDA review of the drug, and he describes the need for an oral therapy and the company's commercial strategy now that the approval is in hand.

en-us

00:15:31

AI News: Singapore based Gero, a company focused on...

BiotechTV - News ·

2025/06/30

Co-Founder & CEO Peter Fedichev describes why he believes reading the amino acid sequences that have been written into the human genome over time is a more realistic way of discovering small molecules that will work rather than via protein-target structure models. He also discovers how the company is leveraging this for its focus on aging conditions and longevity.

en-us

00:13:55

Jones Research analyst Catherine Novack discusses...

BiotechTV - News ·

2025/06/27

She gives a scenario analysis in the event that FDA asked Capricor for more data rather than approving the therapy by its August 31st decision date. Plus, commentary on ProQR, Korro Bio, Wave, Crinetics, Dyne, Rezolute, Larimar, and Aldeyra.

en-us

00:20:31

ArsenalBio's Co-Founder & CEO Ken Drazan talks about...

BiotechTV - News ·

2025/06/27

He describes the ArsenalBio's "CITE" platform, which allows it to make heterogenous cells by inserting modifications all in the same place. Plus, writing in logic gating, harnessing shRNA, and more. The company recently raised a $325M series C.

en-us

00:17:28

Discussing hot button issues for biotech, and how...

BiotechTV - News ·

2025/06/27

He describes how some front and center issues for biotech either do or don't affect the M&A environment such as China, negative enterprise values, the FTC, valuations, the patent cliff, and more.

en-us

00:29:56

William Blair biotech analyst Andy Hsieh takes stock...

BiotechTV - News ·

2025/06/26

He discusses data presented at #ADA25 including Eli Lillys Orforglipron and Bimagrumab, Novo Nordisk's CagriSema, and Amgen's MariTide. Plus, thoughts on Viking's program as it enters phase 3.

en-us

00:16:43

Checking in with the co-founders of Amylyx...

BiotechTV - News ·

2025/06/25

Josh Cohen and Justin Klee walk us through the lead program, avexitide, which is a GLP-1 antagonist and is currently in a pivotal study that will read out in 1H26. Plus, updates on AMX0035 in Wolfram Syndrome and Progressive Supranuclear Palsy, and an ALS program targeting calpain-2 that will have initial data later this year.

en-us

00:11:24

Oxford, UK based Pathios Therapeutics is targeting...

BiotechTV - News ·

2025/06/24

CEO Paul Higham describes the biology of GPR65 inhibition, something that pharma companies have previously tried to do, and explains how cancer patients who genetically have low signaling are seen to have better outcomes in than other genotypes.

en-us

00:08:46

Emeryville based Fauna Bio launched Fauna Brain, an...

BiotechTV - News ·

2025/06/20

Co-Founder Linda Goodman describes the product and the numerous components that go into the scoring.

en-us

00:12:48

The Co-Director of Cardiff University's Medicines...

BiotechTV - News ·

2025/06/20

Simon Ward, Co-Director along with John Atack, describes the founding of the institue and why Cardiff University was a good fit. He describes the goal, to get science through biotech's "valley of death" and to help turn more discoveries from the university into medicines, and how they partner with industry.

en-us

00:17:52

SV Health Investors Managing Partner Kate Bingham...

BiotechTV - News ·

2025/06/20

Kate Bingham describes the type of investments SV makes, which was in the news this week for being the founding investor of the neuropsych company Draig Therapeutics that exited stealth with $140M. Plus, having previously served as the chair of the government's Vaccine Taskforce during COVID, she also shares her thoughts on the evironment in the UK and the MHRA.

en-us

00:10:01

AI News: Alameda based Infinimmune launched its...

BiotechTV - News ·

2025/06/19

Co-Founder and CEO Wyatt McDonnell describes why Infinimmune believes that learning directly from the human adaptive immune system is an ideal way to engineer antibodies, and he describes why he believes the model will be successful for drug development both inside and outside of autoimmune conditions.

en-us

00:10:18

Draig Therapeutics launched from stealth today with a...

BiotechTV - News ·

2025/06/18

An Operating Partner at SV Health Investors, she describes how the company came together after reaching out to Cardiff University Professors John Atack and Simon Ward. She highlights how unusual it is to have clinical proof of concept data already while raising a series A, and why she believes Draig will make a difference for patients.

en-us

00:09:21

BIO International 2025: Sweden's Alligator has a...

BiotechTV - News ·

2025/06/18

CEO Søren Bregenholt describes Alligators phase 2 data, as well as regulatory feedback it has received regarding the phase three trial design. He desribes looking for a partner, and what other cancers the therapy could have utility in. Plus, a next-generation bi-specific targeting CD40 and CEACAM5.

en-us

00:08:30

BIO International 2025: The new CEO of Sweden's Hansa...

BiotechTV - News ·

2025/06/18

Renée Aguiar-Lucander describes the kidney transplant population that the therapy currently has conditional approval with the EMA for, and how Hansa it trying to expand on it. Plus, development work in Guillain-Barré syndrome and gene therapy.

en-us

362 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter